Enanta Pharmaceuticals (ENTA) Research & Development (2016 - 2025)
Historic Research & Development for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $23.8 million.
- Enanta Pharmaceuticals' Research & Development fell 2264.28% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.7 million, marking a year-over-year decrease of 1881.41%. This contributed to the annual value of $106.7 million for FY2025, which is 1881.41% down from last year.
- According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Research & Development is $23.8 million, which was down 2264.28% from $27.2 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Research & Development registered a high of $48.9 million during Q3 2021, and its lowest value of $23.8 million during Q3 2025.
- Over the past 5 years, Enanta Pharmaceuticals' median Research & Development value was $36.4 million (recorded in 2023), while the average stood at $37.0 million.
- As far as peak fluctuations go, Enanta Pharmaceuticals' Research & Development skyrocketed by 3549.97% in 2021, and later crashed by 3313.79% in 2024.
- Enanta Pharmaceuticals' Research & Development (Quarter) stood at $48.5 million in 2021, then dropped by 15.75% to $40.9 million in 2022, then fell by 11.08% to $36.4 million in 2023, then fell by 23.96% to $27.7 million in 2024, then fell by 13.91% to $23.8 million in 2025.
- Its last three reported values are $23.8 million in Q3 2025, $27.2 million for Q2 2025, and $28.1 million during Q1 2025.